DekaBank Deutsche Girozentrale - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$193,000
-19.2%
101,000
-17.9%
0.00%
-33.3%
Q4 2015$239,000
+2.6%
123,000
+0.8%
0.00%0.0%
Q3 2015$233,000
-57.2%
122,000
+3.8%
0.00%
-50.0%
Q2 2015$545,000
+10.3%
117,500
+4.0%
0.01%0.0%
Q1 2015$494,000
+23.2%
113,000
-4.2%
0.01%
+20.0%
Q4 2014$401,000
-25.5%
118,000
-8.2%
0.01%
-28.6%
Q3 2014$538,000
-27.1%
128,500
+2.0%
0.01%
-36.4%
Q2 2014$738,000
-10.9%
126,000
-4.2%
0.01%
-15.4%
Q1 2014$828,000
+13.1%
131,500
+5.6%
0.01%
+8.3%
Q4 2013$732,000
+14.4%
124,500
+2.5%
0.01%
+9.1%
Q3 2013$640,000121,5000.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 10,500,000$17,955,0000.87%
SENZAR ASSET MANAGEMENT, LLC 1,872,191$3,201,447,0000.70%
Virtus ETF Advisers LLC 277,607$475,0000.35%
GLOBEFLEX CAPITAL L P 571,500$977,0000.27%
Lyons Wealth Management, LLC. 42,408$73,0000.11%
TFS CAPITAL LLC 222,736$381,0000.07%
Jacobi Capital Management LLC 35,000$56,0000.03%
Renaissance Technologies 5,601,355$9,578,0000.02%
WELLINGTON MANAGEMENT GROUP LLP 26,725,936$45,701,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 46,300$79,0000.01%
View complete list of ARENA PHARMACEUTICALS INC shareholders